In our CRPC group, both PSA and several meth-ctDNA markers demonstrated similarly strong discriminatory abilities to differentiate between patients with no or any lesion on imaging and non- and metastatic disease presence (Fig. 2). The gene discussed is KLK3; the disease is metastatic neoplasm.